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Abstract
Background: Performing minimally invasive direct coronary artery bypass (MIDCAB) grafting via small chest
incisions on a beating heart is challenging. We report our experiences of MIDCAB with the utilization of both an
improved rib spreader to harvest the left internal mammary artery (LIMA) and a new-shaped cardiac stabilizer to
facilitate LIMA-left anterior descending (LAD) coronary anastomosis.
Methods: Between May 2012 and June 2104, a total of 200 patients who were consecutively operated on in this
period were enrolled in this study. Data reported included demographic information, preoperative clinical and
cardiac status, LIMA harvest time, postoperative in-hospital outcomes, and 30-day mortality.
Results: The average LIMA harvest time was 43 min. The mean age was 62.59 ± 10.19 years, and 45 of the 200
were females. The 30-day mortality was 0.5 % (one patient) due to perioperative myocardial infarction. Duration of
mechanical ventilation and length of stay in intensive care unit was 9.27 ± 7.65 and 24.27 ± 17.85 h, respectively.
The unit of packed RBC transfusion was 0.79 ± 1.58. Postoperative atrial fibrillation was observed in 14 (7 %) patients.
There was no postoperative stroke, renal failure, or incision complication.
Conclusion: Performing MIDCAB with the improved retractor and stabilizer utilized in this study showed favorable
outcomes in terms of harvesting the LIMA, postoperative morbidities, and 30-day mortality.
Keywords: Minimally invasive direct coronary artery bypass (MIDCAB), Beating heart, Off-pump coronary artery surgery,
Rib spreader, Cardiac stabilizer
Background
Minimally invasive direct coronary artery bypass
(MIDCAB) grafting attempts to achieve adequate coron-
ary artery revascularization in a less invasive manner than
conventional coronary artery bypass grafting (CABG).
Unlike conventional revascularization techniques, which
are highly invasive due to the use of a large incision
(sternotomy) and cardiopulmonary bypass (CPB), MID-
CAB limits invasiveness by employing a small incision
(thoracotomy) and by operating on the beating heart to
avoid the need for CPB [1]. By limiting invasiveness in
these ways, MIDCAB can reduce the risk of complications
such as infection and stroke [2]. In comparison to conven-
tional CABG and off-pump CABG (via a sternotomy),
MIDCAB can improve early post-operative quality of life
[3] and recovery time [4], respectively.
While MIDCAB can lead to favorable outcomes, per-
forming coronary anastomosis via a small chest incision
on a beating heart can be challenging [5]. This makes it
difficult to accomplish two key aspects of the MIDCAB
procedure. The first pertains to obtaining an adequate
length of left internal mammary artery (LIMA) [6] and
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the second is in regard to adequately stabilizing the
wall of the beating heart, without adversely affecting
hemodynamics or injuring the myocardium [7]. To
overcome these difficulties, a variety of retractors and
cardiac stabilizers have been utilized, but there is
interest in improving their design [8].
Recently, we started utilizing a Fehling retractor (Fehling,
Germany), a rib spreader, to harvest the LIMA under direct
vision. Compared to existing retractors, this improved re-
tractor allows for an expanded field of vision and enhances
LIMA exposure [9]. Additionally, we started using a newly
developed stabilizer during MIDCAB. Compared to exist-
ing stabilizers, this stabilizer has a better shape to facilitate
anastomosing the deeply located left anterior descending
(LAD) coronary artery, and can be applied with light pres-
sure, thereby reducing the risk of adverse hemodynamic ef-
fects and myocardial injury. In theory, these new and
improved devices might lead to improved patient outcomes
during MIDCAB, but empirical data are needed to fully as-
sess this issue. Accordingly, the present study reported out-
comes in patients who underwent MIDCAB using both the
Fehling retractor and the improved cardiac stabilizer.
Methods
This descriptive, non-experimental study included a total
of 200 consecutive patients, who were scheduled to
undergo a MIDCAB operation at our institution between
May 2012 and June 2014. All patients were treated by a
single surgeon at the Department of Cardiac Surgery of
Peking University People’s Hospital. The study was
approved by the institutional ethics committee of the
Department of Cardiac Surgery of Peking University
People’s Hospital, and all study patients provided written
informed consent prior to surgery.
Surgical procedures and technique
Double-cavity tracheal cannulas were used along with
general anesthesia. Patients were placed in the supine pos-
ition, with the left chest raised by 30°. A 5–6 cm surgical
incision was then made in the area of the fourth or fifth
rib, and the thoracic cavity was entered. To enable LIMA
harvesting, a specialized suspensory internal mammary ar-
tery retraction system was utilized (Fig. 1). This retractor
offers advantages compared to other retractors in that it
can integrally raise the left chest wall, thereby avoiding ex-
cessive traction of local ribs while simultaneously provid-
ing a good operative field to facilitate obtaining adequate
LIMA. LIMA was harvested from the upper segment to
the lower segment, and LIMA branches were clipped
using a pen titanium clamp.
Beating heart LIMA-LAD anastomosis was facilitated
by a heart stabilizer specially designed for MIDCAB pro-
cedures (HK, Figs. 2 and 3). This stabilizer is unique in
that its presser foot has an “L”-shape, which is particularly
advantageous for procedures performed within a deep
space, such as MIDCAB. A second advantage of this
stabilizer is that it can be placed on a rib retractor without
an external fixator. Because of these two advantages, the
stabilizer’s presser foot only needs to be in light contact
with the epicardium to achieve stability through negative
pressure suction. This light contact limits squeezing pres-
sure on the heart, and thereby reduces the risk of circula-
tory instability. Additionally, the stabilizer has a reduced
number of adsorption holes and a reduced adsorption area
on the sucker, both of which help to limit the myocardial
area that could potentially be damaged by the stabilizer.
After incising the coronary artery, routine coronary artery
bypass grafting was performed, and 8-0 prolene lines were
utilized to perform a continuous suture. All of the 200
Fig. 1 Suspensory internal mammary artery retraction system
Fig. 2 L-shaped suction stabilizer foot
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study subjects underwent LIMA-LAD single bypass
during the MIDCAB.
Data collection
Prior to surgery, subjects’ height and weight were mea-
sured and questionnaires were administered to collect pa-
tient’s age, gender, history of medical conditions, and
history of cardiovascular procedures. Pre-operative mea-
surements were made of each patient’s ejection fraction
and angiographic status and stored in a hospital database
for subsequent access. Study personnel also collected data
on procedure duration and other in-hospital outcomes and
complications. After the patients were discharged from the
hospital, they were followed up as outpatients to obtain
the information regarding 30-day mortality. Data were
available on all 200 patients. Patient data were examined
and presented by descriptive statistics. Setting the Type I
error rate at 0.05 and the drop-out rate at 10 %, a power
analysis [10] showed that to detect a proportion of 0.07, a
sample size of 194 patients would be sufficient to achieve a
statistical power of 80 % at a 5 % significance level. This
study included a total of 200 patients, which satisfied the
required sample based on the post hoc analysis.
Results
The average LIMA harvest time was 43 min. The pre-
operative characteristics of the patients are displayed in
Table 1. The patients included 138 individuals that re-
ceived MIDCAB alone and 62 individuals that underwent
hybrid procedure (MIDCAB for LAD, plus percutaneous
coronary intervention (PCI) for other blood vessels). The
mean age was 62.59 ± 10.19 years, and 45 of the 200 were
females.
Table 2 shows the in-hospital outcomes and 30-day
mortality. One (0.5 %) patient died within 30 days due to
perioperative myocardial infarction (MI). Duration of
mechanical ventilation was 9.27 ± 7.65 h and length of
stay in intensive care unit was 24.27 ± 17.85 h. The unit
of packed RBC transfusion was 0.79 ± 1.58. Postoperative
atrial fibrillation (PAF) was observed in 14 (7 %) pa-
tients. No patient had experienced stroke, renal failure,
or incision complication.
Discussion
In this study of the MIDCAB procedure using an im-
proved retractor and stabilizer, we found the following in-
hospital outcomes: an average LIMA harvest time of
43 min, a mean duration of mechanical ventilation of 9 h,
Fig. 3 Schematic diagram of cardiac stabilizer
Table 1 Preoperative patient characteristics (N = 200)
MIDCAB Hybrid Total
(n = 138) (n = 62) (N = 200)
Age, year 63.65 ± 10.48 60.24 ± 9.18 62.59 ± 10.19
Sex, N (%) of female 35 (25.4 %) 10 (16.1 %) 45 (22.5 %)
Height, cm 167.08 ± 7.4 168.3 ± 6.32 167.45 ± 7.1
Weight, kg 70.69 ± 10.53 71.73 ± 9.52 71.01 ± 10.21
Hypertension, N (%) 80 (58.0 %) 26 (41.9 %) 106 (53.0 %)
Diabetes mellitus, N (%) 40 (29.0 %) 27 (43.5 %) 67 (33.5 %)
Smoking, N (%) 63 (45.7 %) 33 (53.2 %) 96 (48.0 %)
Hypercholesterolemia, N (%) 20 (14.5 %) 9 (14.5 %) 29 (14.5 %)
Old MI, N (%) 40 (29.0 %) 17 (27.4 %) 57 (28.5 %)
PCI history, N (%) 17 (12.3 %) 0 (0.0 %) 17 (8.5 %)
Renal insufficiency, N (%) 4 (2.9 %) 0 (0.0 %) 4 (2.0 %)
NYHA grade 1-2, N (%) 120 (87.0 %) 55 (88.7 %) 175 (87.5 %)
NYHA grade 3, N (%) 18 (13.0 %) 7 (11.3 %) 25 (12.5 %)
LVEF, N (%)
> 55 % 114 (82.6 %) 52 (83.9 %) 166 (83.0 %)
46–55 % 16 (11.6 %) 3 (4.8 %) 19 (9.5 %)
36–45 % 7 (5.1 %) 6 (9.7 %) 13 (6.5 %)
≤ 35 % 1 (0.7 %) 1 (1.6 %) 2 (1.0 %)
LVEDd, mm 50.16 ± 5.96 50.52 ± 5.76 50.27 ± 5.89
Single-vessel disease 89 (64.5 %) 0 (0.0 %) 89 (44.5 %)
Left main or multi-vessel
disease
49 (35.5 %) 62 (100.0 %) 111 (55.5 %)
LVEF, left ventricular ejection fractions; LVEDd, left ventricular end diastolic
diameter; MI, myocardial infarction; NYHA, New York Heart Association; PCI,
Percutaneous coronary intervention
Table 2 In-hospital clinical outcomes and 30-day mortality (N= 200)
MIDCAB Hybrid Total
(n = 138) (n = 62) (N = 200)
30-day mortality, N (%) 1 (0.7 %) 0 (0.0 %) 1 (0.5 %)
Perioperative MI, N (%) 1 (0.7 %) 0 (0.0 %) 1 (0.5 %)
Duration of mechanical
ventilation, hour
9.93 ± 8.65 7.79 ± 4.43 9.27 ± 7.65
LOS in ICU, hour 24.17 ± 17.83 24.48 ± 18.03 24.27 ± 17.85
PRBC, units 0.86 ± 1.63 0.61 ± 1.47 0.79 ± 1.58
PAF, N (%) 10 (7.2 %) 4 (6.5 %) 14 (7.0 %)
Stroke, N (%) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %)
Renal failure, N (%) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %)
Incision complications, N (%) 0 (0.0 %) 0 (0.0 %) 0 (0.0 %)
ICU, intensive care unit; LOS, length of stay; MI, myocardial infarction; PAF,
postoperative atrial fibrillation; PRBC, packed red blood cell
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and a mean ICU stay of 24 h. PAF occurred in only 7 % of
the patients, and there was no postoperative stroke, renal
failure, or incision complications. The 30-day mortality
rate was 0.5 %. Together, these data suggest that perform-
ing MIDCAB with the improved retractor and stabilizer
used in this study can lead to favorable outcomes.
The MIDCAB procedure was introduced into the surgi-
cal literature in 1995 [11]. Subsequently, MIDCAB was
adopted by various universities and hospitals in Europe
and America [12]. Reports indicate that MIDCAB not only
has comparable patency rates with off-pump CABG (via
sternotomy) [13] and conventional CABG [14] but leads
to favorable outcomes such as shorter hospitalization [4],
faster recovery [4], and less need for blood transfusion
[15]. Initially, MIDCAB procedures were performed using
chest wall retraction under direct vision. However, retrac-
tion of the chest wall could lead to postoperative pain and
obtaining LIMA under direct vision could be technically
challenging. Consequently, some centers started to per-
form MIDCAB using robotic surgery, yet the robotically
assisted approach has a significant learning curve and
major costs [11]. As such, MIDCAB using chest wall re-
traction under direct vision remains a reasonable, afford-
able approach for developing nations [16, 17] such as
China, but concerns remain about pain due to the retrac-
tion and about hemodynamic instability and myocardial
injury due to the use of cardiac stabilizers.
To address concerns about retraction-associated pain,
hemodynamic instability, and myocardial injury, we per-
formed MIDCAB operations during the past two years
using an improved retractor and a new-shaped cardiac
stabilizer. The retractor is a suspensory internal mam-
mary artery retraction system that facilitates obtaining
LIMA under direct vision. In particular, this retractor
raises the anterior chest wall integrally, which allows the
surgeon to work within a good operative space without
having to retract the chest wall excessively. This allows
for adequate LIMA harvesting while limiting pain due to
retraction. The newly developed stabilizer has an L-
shaped presser foot, the shape of which is advantageous
for operating within the deep but narrow opening in
which MIDCAB procedures take place; furthermore, the
stabilizer can be placed on a rib spreader without an ex-
ternal fixator. As such, the stabilizer need only exert
light pressure on the epicardium in order to achieve ad-
equate coronary stabilization through negative pressure
suction. In this way, the stabilizer reduces the risk of ad-
verse hemodynamic events. Moreover, the stabilizer has
a relatively small number of adsorption holes covering a
relatively small area on the sucker, and therefore, re-
duces the area of myocardium that is at risk of damage
from stabilizer-induced contact.
Data from our study suggest that MIDCAB procedures
performed with the improved retractor and stabilizer
had favorable outcomes. The average time to obtain LIMA
was 43 min, which is shorter than in some studies using
robotic devices. Fujita et al. successfully performed MID-
CAB surgery with robotic LIMA harvesting in 30/33
patients; their average harvest time was 68 min [18]. In
another report of robotic endoscopic LIMA harvesting in
100 cases, the reported median harvest time was 48 min;
however, there was a significant learning curve so that the
harvest time decreased with experience, from 140 min in
the first 10 cases to 40 min in the last 10 cases [19]. The
harvest time of 43 min in the current study using an im-
proved retractor and stabilizer compares favorably with
these two reports using robotic techniques.
Internal mammary artery injuries were not found in
any of the patients in the current study. In Fujita’s study,
3/33 patients (9 %) had bleeding from the LIMA requir-
ing conversion to a median sternotomy [18]. Addition-
ally, there were 4 cases of LIMA injury in Oehlinger’s
series, 3 (6 %) during the first half of their experience
and 1 (2 %) during the second half. Additionally, one pa-
tient required median sternotomy because of LIMA in-
jury during robotic harvesting [19]. Thus, the technique
in the current study provided better results in terms of
arterial injuries compared with these prior studies using
robotic techniques.
Mechanical ventilation is another parameter of con-
cern. A retrospective analysis of 217 patients who under-
went MIDCAB in Germany was performed with a focus
on fast-track recovery [20]. In that study, extubation was
performed immediately after surgery in 182 (83.9 %) pa-
tients, only 8 of whom required re-intubation within one
hour of arrival in the ICU. Of the remaining 35 patients,
31 required ventilation for <24 h, and 4 patients re-
quired >72 h of ventilation [20]. Another group in
Germany compared their results for patients undergoing
surgery with a full sternotomy (OPCAB, n = 44) and
those undergoing MIDCAB procedures (n = 58); they
generally found that MIDCAB was more challenging and
had worse results. For example, although there was no
perioperative mortality in either group, time on the venti-
lator was longer in the MIDCAB compared with the
OPCAB group (29 ± 109 h vs 10 ± 6 h, NS) [21]. The time
in the ICU was 57 ± 129 h vs 32 ± 14 h for the OPCAB
and MIDCAB groups, respectively [21]. Bisbos et al.
reported their experience with MIDCAB in 91 patients
in Greece; the mean ICU stay was 29 ± 4 h [22]. In the
current study, the duration of mechanical ventilation
was 9.93 ± 8.65 h, and the length of ICU stay was
24.17 ± 17.83 h, again comparing favorably with prior
studies.
In-hospital complications with MIDCAB procedures
may include PAF, stroke, renal failure, and incision com-
plications. McGinn et al. reported on the results of 450
minimally invasive coronary artery bypass surgeries at
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two centers in the US and found the following complica-
tions: stroke, n = 2 (0.4 %); new-onset atrial fibrillation,
n = 111 (24.4 %); new-onset renal failure, n = 12 (2.9 %);
and wound infection, n = 4 (0.9 %) [23]. In the current
study, the rates of these complications were less: only 7 %
of patients developed atrial fibrillation, and no patients de-
veloped stroke, renal failure, or incision complications.
Additionally, the 30-day mortality rate was less than 1 %
in the current study. In a report of the experience with
MIDCAP cases from a single center in the Czech Republic,
there was a 30-day mortality rate of 1.3% (2/149 patients)
[24]. Similarly, an early (<30 days) mortality rate of 1.3 %
(51/4081 patients) was reported in a meta-analysis of 17
studies utilizing MIDCAB grafting [25]. The 30-day mor-
tality rate in the current study compares favorably with
these results.
There are several limitations of this study. First, it is
observational in nature, with the inherent bias involved
in such studies. Also, there was no direct comparison
group, so that all comparisons were with the published
literature. Since the patients in these prior publications
may not be similar populations, firm conclusions cannot
be made although the findings in the current study
seemed to compare favorably with historical results. Sig-
nificantly, no patency rates, long-term follow-up or
long-term outcomes were available from the current
study. Therefore, further studies are needed to better de-
fine the full range of outcomes with the new techniques
described in the current study.
Conclusions
Taken together, the two devices have the following clin-
ical benefits. The suspensory internal mammary artery
retraction system utilized in the current study shortens
the LIMA harvest time and minimizes the risk of dam-
aging the internal mammary arteries. In addition, the re-
tractor allows for obtaining the LIMA under direct
vision, which facilitates harvesting an adequate length of
LIMA via a small surgical incision in the left side of the
chest. The newly developed cardiac stabilizer is advanta-
geous in regard to maintaining intraoperative circulatory
stability and reducing the risk of injuring the myocar-
dium. Furthermore, this study suggests that performing
MIDCAB with the improved retractor and stabilizer can
lead to favorable outcomes in terms of postoperative
morbidity and 30-day mortality.
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